|
|||||
|
|
A randomized,double‐blind,crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already established on regular opioids |
|
| Authors: | David C. Currow Katherine Clark Sandra Louw Belinda Fazekas Aine Greene Christine R. Sanderson |
| Abstract: | |
| Keywords: | |